Entry inhibitors

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Generic term for drugs that prevent the binding of the HI virus to the cell membrane of CD4-positive cells. S.u. Enfuvirtide.

EffectsThis section has been translated automatically.

When HIV enters the CD4 cell, there are three key sites to prevent contact: the binding of HIV to the CD4 receptor, the binding to coreceptors and finally the fusion of virus and cell. Entry inhibitors prevent the fusion of virus and target cell.

IndicationThis section has been translated automatically.

Therapy of HIV infections; preparations are prescribed in combination with other antiretroviral drugs (see below HAART).

Undesirable effectsThis section has been translated automatically.

The most important adverse effects of the respective drugs are listed in table form under HIV infection.

LiteratureThis section has been translated automatically.

  1. Plettenberg A et al (2003) RADATA - an expert system for the optimization of antiviral therapy decisions. Documentation and analysis of disease progression. Fuzeon cohort. www.radata.de

Authors

Last updated on: 29.10.2020